๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer?

โœ Scribed by Charles N Bernstein; James F Blanchard; Colleen Metge; Marina Yogendran

Book ID
119187517
Publisher
Nature Publishing Group
Year
2003
Tongue
English
Weight
53 KB
Volume
98
Category
Article
ISSN
0002-9270

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Colorectal cancer prevention in inflamma
Colorectal cancer prevention in inflammatory bowel disease and the role of 5-aminosalicylic acid: A clinical review and update
โœ David T. Rubin; Marcia R. Cruz-Correa; Christoph Gasche; Jeremy R. Jass; Gary R. ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 203 KB ๐Ÿ‘ 2 views

A roundtable consensus meeting was held to consolidate current knowledge on the etiology of colorectal cancer in patients with inflammatory bowel disease and to review current strategies, both diagnostic and preventive, specifically addressing the role of 5-aminosalicylic acid. Specific topics that

5-Aminosalicylic acid therapy and the ri
5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease
โœ Jonathan P. Terdiman; Michael Steinbuch; William A. Blumentals; Thomas A. Ullman ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 77 KB ๐Ÿ‘ 2 views

## Background: Patients with inflammatory bowel disease (ibd) affecting the colon are at increased risk of developing colorectal cancer (crc). published data are conflicting about whether 5-aminosalicylic acid (5-asa) has chemopreventive properties against ibd-related carcinogenesis. the objective